# Study of Human Central Nervous System (CNS) Stem Cell Transplantation in Cervical Spinal Cord Injury

> **NCT02163876** · PHASE2 · TERMINATED · sponsor: **StemCells, Inc.** · enrollment: 31 (actual)

## Conditions studied

- Cervical Spinal Cord Injury
- Spine Injury
- Cervical Spine Injury

## Interventions

- **DRUG:** HuCNS-SC cells

## Key facts

- **NCT ID:** NCT02163876
- **Lead sponsor:** StemCells, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2014-10
- **Primary completion:** 2016-05
- **Final completion:** 2016-05
- **Target enrollment:** 31 (ACTUAL)
- **Why stopped:** Based on a business decision unrelated to any safety concerns.
- **Last updated:** 2016-06-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02163876

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02163876, "Study of Human Central Nervous System (CNS) Stem Cell Transplantation in Cervical Spinal Cord Injury". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02163876. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*